Skip to content

The Effect of Macronutrients on Satiety and Gut Hormone Responses

A Physiological Study on the Effect of Macronutrients Delivery to the Proximal and Distal Small Bowel on Satiety and Gut Hormone Responses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03466047
Acronym
Microcapsule
Enrollment
8
Registered
2018-03-15
Start date
2018-03-15
Completion date
2019-01-01
Last updated
2020-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eating Behavior

Brief summary

This study is part of a research theme aiming at elucidating the physiological mechanisms of action of weight loss after gastric bypass surgery. The Roux-en-Y Gastric Bypass procedure induces pronounced and sustained weight loss, but the physiological mechanisms of action are not completely clear. Neither mechanical restriction of food intake nor malabsorption, are the main contributing factors. The enhanced postprandial responses of gut hormones (e.g. GLP-1 and PYY) which increase satiety as well as energy expenditure after surgery suggest a changed physiological set point for appetite and metabolism. Our hypothesis is that the intake of high quantity of protein in a microcapsule form would be able to reach the distal parts of the intestinal mucosa and stimulate maximum stimulation of the anorectic gut hormones. The higher functions of the brain will respond to these strong neuroendocrine signals by ensuing satiety and fullness.

Detailed description

Ten healthy volunteers, aged 18 to 65 years will be recruited. Each subject will be studied on six occasions one week apart. On each visit, a baseline serum sample will be drawn from each subject. In a randomized way all subjects will receive the following meals in their successive weekly visits: Option 1 High protein mixed meal in capsules that break down in the stomach, Option 2 High protein mixed meal in capsules that break down in the distal small bowel, Option 3 High fat mixed meal in capsules that break down in the stomach, Option 4 High fat mixed meal in capsules that break down in the distal small bowel, Option 5 High CHD mixed meal in capsules that break down in the stomach, Option 6 High CHD mixed meal in capsules that break down in the distal small bowel. On the same day, all subjects will be offered standard ad libitum meal to measure their food consumption. After 3 hours (i.e. at 12:00) another blood sample will be drawn. All subjects will be asked to rate their appetite on a Visual Analogue Scale (VAS). Upon VAS completion the subjects will be allowed to go home.

Interventions

DIETARY_SUPPLEMENTProtein stomach

encapsulated protein stomach

DIETARY_SUPPLEMENTProtein distal small intestine

encapsulated protein distal small intestine

DIETARY_SUPPLEMENTCHO stomach

encapsulated CHO stomach

DIETARY_SUPPLEMENTCHO distal small intestine

encapsulated CHO distal small intestine

DIETARY_SUPPLEMENTFat stomach

encapsulated Fat stomach

DIETARY_SUPPLEMENTFat distal small intestine

encapsulated Fat distal small intestine

Sponsors

Imperial College London
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* 18-65 years * Normal fasting glucose * Stable body weight for at least last three months * BMI \< 30 Kg/m2 * Capacity to consent to participate * Independently mobile

Exclusion criteria

* Patients who meet any of the following criteria will be excluded: * Pre-diabetes Diabetes * Obesity * Smoking * Substance abuse * Pregnancy * Use of medications (except for oral contraceptives) * Chronic medical or psychiatric illness * Any significant abnormalities detected on physical examination, electrocardiography, or screening blood tests (measurement of complete blood count, electrolytes, fasting glucose, and liver function)

Design outcomes

Primary

MeasureTime frameDescription
The Effect of Proteins on the Secretion of Gut Hormones From Different Parts of the Gastrointestinal Tract3 hours3 hours AUC for different gut hormones (PYY) to determine the response to macronutrients in different release (stomach vs small intestine) locations. AUC for timepoints 0, 30min, 60min, 120min, 180min.

Secondary

MeasureTime frameDescription
Total Intake (kj) of ad Libitum Lunch Meals to Assess Food Intake3 hoursFood intake as assessed with ad libitum lunch 3 hours after intervention
Visual Analogue Scale Ratings of Hunger180minVisual Analogue Scale ratings of hunger at 180 min (before the meal). The scale is 10cm line with two anchors at each end. Scores are recorded by making a handwritten mark that represents a continuum between not hungry at all and Extremly hungry. The score of 0 represents least hunger. The score of 10 represent extreme hunger.

Countries

Ireland

Participant flow

Participants by arm

ArmCount
Interventions
Encapsulated macronutrients in a drink, 6 experiments, Protein released in the stomach (1 day), Protein released in the small intestine (1 day), CHO released in the stomach (1 day), CHO released in the small intestine (1 day), Fat released in the stomach (1 day), fat released in the small intestine (1 day).
8
Total8

Baseline characteristics

CharacteristicInterventions
Age, Continuous28.8 years
STANDARD_DEVIATION 3.5
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
8 Participants
Region of Enrollment
Ireland
8 participants
Sex/Gender, Customized
Women
3 Participants
Weight81.8 kg
STANDARD_DEVIATION 7.2

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
EG005
affected / at risk
deaths
Total, all-cause mortality
0 / 80 / 80 / 80 / 80 / 80 / 8
other
Total, other adverse events
0 / 80 / 80 / 80 / 80 / 84 / 8
serious
Total, serious adverse events
0 / 80 / 80 / 80 / 80 / 80 / 8

Outcome results

Primary

The Effect of Proteins on the Secretion of Gut Hormones From Different Parts of the Gastrointestinal Tract

3 hours AUC for different gut hormones (PYY) to determine the response to macronutrients in different release (stomach vs small intestine) locations. AUC for timepoints 0, 30min, 60min, 120min, 180min.

Time frame: 3 hours

ArmMeasureValue (MEAN)Dispersion
Protein StomachThe Effect of Proteins on the Secretion of Gut Hormones From Different Parts of the Gastrointestinal Tract1310 pg*min/mLStandard Error 102
Fat StomachThe Effect of Proteins on the Secretion of Gut Hormones From Different Parts of the Gastrointestinal Tract1073 pg*min/mLStandard Error 154
CHO StomachThe Effect of Proteins on the Secretion of Gut Hormones From Different Parts of the Gastrointestinal Tract1118 pg*min/mLStandard Error 150
Protein Distal Small IntestineThe Effect of Proteins on the Secretion of Gut Hormones From Different Parts of the Gastrointestinal Tract1188 pg*min/mLStandard Error 121
Fat Distal Small IntestineThe Effect of Proteins on the Secretion of Gut Hormones From Different Parts of the Gastrointestinal Tract1725 pg*min/mLStandard Error 351
CHO Distal Small IntestineThe Effect of Proteins on the Secretion of Gut Hormones From Different Parts of the Gastrointestinal Tract1194 pg*min/mLStandard Error 221
Secondary

Total Intake (kj) of ad Libitum Lunch Meals to Assess Food Intake

Food intake as assessed with ad libitum lunch 3 hours after intervention

Time frame: 3 hours

ArmMeasureValue (MEAN)Dispersion
Protein StomachTotal Intake (kj) of ad Libitum Lunch Meals to Assess Food Intake3138 kjStandard Deviation 175
Fat StomachTotal Intake (kj) of ad Libitum Lunch Meals to Assess Food Intake3389 kjStandard Deviation 161
CHO StomachTotal Intake (kj) of ad Libitum Lunch Meals to Assess Food Intake3146 kjStandard Deviation 168
Protein Distal Small IntestineTotal Intake (kj) of ad Libitum Lunch Meals to Assess Food Intake3008 kjStandard Deviation 192
Fat Distal Small IntestineTotal Intake (kj) of ad Libitum Lunch Meals to Assess Food Intake3690 kjStandard Deviation 170
CHO Distal Small IntestineTotal Intake (kj) of ad Libitum Lunch Meals to Assess Food Intake2305 kjStandard Deviation 183
Secondary

Visual Analogue Scale Ratings of Hunger

Visual Analogue Scale ratings of hunger at 180 min (before the meal). The scale is 10cm line with two anchors at each end. Scores are recorded by making a handwritten mark that represents a continuum between not hungry at all and Extremly hungry. The score of 0 represents least hunger. The score of 10 represent extreme hunger.

Time frame: 180min

ArmMeasureValue (MEAN)Dispersion
Protein StomachVisual Analogue Scale Ratings of Hunger5.4 cmStandard Deviation 0.5
Fat StomachVisual Analogue Scale Ratings of Hunger5.5 cmStandard Deviation 0.5
CHO StomachVisual Analogue Scale Ratings of Hunger3.8 cmStandard Deviation 0.7
Protein Distal Small IntestineVisual Analogue Scale Ratings of Hunger4.1 cmStandard Deviation 0.6
Fat Distal Small IntestineVisual Analogue Scale Ratings of Hunger4.1 cmStandard Deviation 0.4
CHO Distal Small IntestineVisual Analogue Scale Ratings of Hunger4.1 cmStandard Deviation 0.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026